Begin main content

Ticagrelor

Last Updated: June 1, 2011
Result type: Reports
Project Number: S0234
Product Line: Common Drug Review

Generic Name: Ticagrelor

Brand Name: Brilinta

Manufacturer: AstraZeneca Canada Inc

Indications: Thrombotic events in Acute Coronary Syndromes, Prevention

Submission Type: New

Project Status: Complete

Date Recommendation Issued: December 16, 2011

Recommendation Type: Do not list